Key Points
- John Gottwald, a major shareholder, sold 3,418 Tredegar shares on Feb. 18 at an average price of $8.87 for about $30,318, trimming his stake by 0.58% to 583,968 shares; the sale was disclosed in an SEC filing.
- Tredegar shares traded at $8.79 (up ~0.5%) with a market cap of roughly $306.9M, a 52‑week range of $6.25–$9.43, and a negative trailing P/E of -5.56.
- Analyst views are mixed but weak on average — MarketBeat reports an average rating of "Sell" (individual ratings range from sell to strong-buy) — and institutional investors own about 79% of the stock.
Tredegar Corporation (NYSE:TG - Get Free Report) major shareholder John Gottwald sold 3,418 shares of Tredegar stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $8.87, for a total value of $30,317.66. Following the completion of the sale, the insider owned 583,968 shares of the company's stock, valued at $5,179,796.16. The trade was a 0.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
Tredegar Stock Up 0.5%
Shares of NYSE TG traded up $0.04 during trading on Friday, reaching $8.79. 28,726 shares of the company traded hands, compared to its average volume of 165,626. The firm has a 50 day simple moving average of $8.13 and a 200-day simple moving average of $7.86. Tredegar Corporation has a 52-week low of $6.25 and a 52-week high of $9.43. The stock has a market capitalization of $306.86 million, a PE ratio of -5.56 and a beta of 0.65.
Wall Street Analyst Weigh In
Several brokerages have issued reports on TG. Weiss Ratings reissued a "sell (d-)" rating on shares of Tredegar in a research report on Wednesday, January 21st. Wall Street Zen raised shares of Tredegar from a "hold" rating to a "strong-buy" rating in a report on Saturday, November 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Tredegar currently has an average rating of "Sell".
Get Our Latest Stock Analysis on TG
Institutional Investors Weigh In On Tredegar
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its holdings in Tredegar by 531.0% during the third quarter. Russell Investments Group Ltd. now owns 3,376 shares of the basic materials company's stock valued at $27,000 after purchasing an additional 2,841 shares in the last quarter. Torren Management LLC purchased a new stake in shares of Tredegar in the fourth quarter worth $32,000. BNP Paribas Financial Markets raised its position in shares of Tredegar by 53.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,273 shares of the basic materials company's stock valued at $42,000 after purchasing an additional 1,830 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Tredegar by 225.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,889 shares of the basic materials company's stock valued at $61,000 after buying an additional 4,771 shares in the last quarter. Finally, Heron Bay Capital Management bought a new position in Tredegar in the 4th quarter worth $76,000. 79.24% of the stock is owned by hedge funds and other institutional investors.
About Tredegar
(
Get Free Report)
Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar's operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.
The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
